CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

(2017) Marko Babjuk et al.   EUROPEAN UROLOGY

CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma

(2017) Ming Tu et al.   Molecular Medicine Reports

Bladder cancer

(2017) Michelle Grayson   NATURE

Virtual Double Staining

(2017) Nina Lykkegaard Andersen et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Expression of CD164 on Malignant T cells in Sézary Syndrome

(2016) E Guenova et al.   ACTA DERMATO-VENEREOLOGICA

CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214

(2016) Bernice M. Benoit et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Bladder cancer

(2016) Ashish M Kamat et al.   LANCET

Impact of 2004 ISUP/WHO classification on bladder cancer grading

(2015) Soum D. Lokeshwar et al.   WORLD JOURNAL OF UROLOGY

miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164

(2014) JIA-ANG SHI et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Improving the TNM classification: Findings from a 10-year continuous literature review

(2013) Colleen Webber et al.   INTERNATIONAL JOURNAL OF CANCER

CD164 and FCRL3 Are Highly Expressed on CD4+CD26 − T Cells in Sézary Syndrome Patients

(2013) Maria Wysocka et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis

(2013) Ai-Fang Huang et al.   Molecular Cancer

Inhibiting CD164 Expression in Colon Cancer Cell Line HCT116 Leads to Reduced Cancer Cell Proliferation, Mobility, and Metastasisin vitroandin vivo

(2012) Jingqun Tang et al.   CANCER INVESTIGATION

Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke

(2012) Xiaolan Yu et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer

(2011) E. Righi et al.   CANCER RESEARCH

CXCR4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer

(2011) Nozomu Sakai et al.   CLINICAL & EXPERIMENTAL METASTASIS

CD164 and other recently discovered activation markers as promising tools for allergy diagnosis: what’s new?

(2011) Salvatore Chirumbolo   CLINICAL AND EXPERIMENTAL MEDICINE

The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling

(2011) Yi-fang Ping et al.   JOURNAL OF PATHOLOGY

Bladder Cancer in 2010: How Far have We Come?

(2010) B. L. Jacobs et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases

(2010) Daisuke Uchida et al.   EUROPEAN JOURNAL OF CANCER

Mechanisms of recurrence of Ta/T1 bladder cancer

(2010) Richard T Bryan et al.   ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND

Regulation of Myoblast Motility and Fusion by the CXCR4-associated Sialomucin, CD164

(2008) Gyu-Un Bae et al.   JOURNAL OF BIOLOGICAL CHEMISTRY